Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Set against a backdrop of collaboration and urgency, the first HCM Summit Toronto 2016 assembled 30 global physician-leaders to address the diagnosis and treatment of a rare but often fatal cardiac condition: hypertrophic cardiomyopathy (HCM).
The purpose of the HCM Summit Toronto 2016 - the first international conference on HCM - is to craft recommendations for management of the potentially-fatal disease.
Organized by Dr. Harry Rakowski, cardiologist, Peter Munk Cardiac Centre, UHN; Professor of Medicine, University of Toronto, and a leading authority on HCM, the Summit convened physicians from five continents. The Summit represented notable institutions such as the Mayo Clinic, Harvard Medical School, and the Cleveland Clinic, among others.
"It was a remarkable meeting, bringing together the best scientific minds in HCM from around the world to identify the greatest challenges in disease management and to collaboratively speak the same language and follow the same path of discovery," says Dr. Rakowski.
Dr. Rakowski considers this meeting critical in achieving consensus on treatment of HCM patients, which he describes as often "challenging" for physicians.
HCM affects one in 500 Canadians and often presents with few notable symptoms. It is also one of the leading causes of sudden cardiac death.
"The Summit provided a unique opportunity for discussion on a number of crucial topics concerning HCM diagnosis, management and research," says attendee, Dr. Iacopo Olivotto, Director, Referral Center for Cardiomyopathies, Careggi University Hospital, Florence, Italy.
"The format allowed ample and comprehensive discussion, by limiting the time of conventional presentations. Furthermore, the atmosphere was warm and passionate, helping overcome differences in opinions."
"The most important deliverable is to set in motion a process of re-unification of HCM guidelines, currently divided between the American College of Cardiology, the American Heart Association and the European Society of Cardiology," says Dr. Olivotto.
"Points in common are much more relevant than differences. I think we will be able to implement a large network encompassing existing registries and collaborations," he says. "This could only have happened in Canada! Our hosts have been magnificent in every possible way."
For Dr. Rakowski, who is also the Douglas Wigle Research Chair in Hypertrophic Cardiomyopathy, and who conceived the idea for the Summit just three months ago, the effort is already bearing fruit.
"There has been a remarkable consensus developed in two days for what we need to do. A Proceedings paper will follow and perhaps one or two other papers that separately review Genetics and Septal Reduction strategies," he says.